Skip to content

Clinical trials

Phase 2 Lung Neoplasms trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 2 Country / region: Hungary Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20081
20111
20141
20171
20182
20223
20231
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting5
Active, not recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Amgen1
Apollomics Inc.1
AstraZeneca1
Daiichi Sankyo1
Human Genome Sciences Inc.1
ImmunoGenesis1
Incyte Corporation1
Infinity Pharmaceuticals, Inc.1
Mirati Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms17
Carcinoma, Non-Small-Cell Lung12
Neoplasms2
Pancreatic Neoplasms2
Stomach Neoplasms2
Urinary Bladder Neoplasms2
Brain Neoplasms1
Breast Neoplasms1
Carcinoma, Large Cell1
Carcinoma, Squamous Cell1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.